Abstract
The 54th American Society of Clinical Oncology (ASCO) Annual Meeting took place between 1st and 5th June in Chicago (USA) united more than 40,700 professionals of various fields. Oncological urology topics account for a considerable proportion of the Annual Meeting proceedings. In this article, a review of the most significant reports on cancer urology from the ASCO 2018 Annual Meeting is presented.
Highlights
Съезды и конференцииОбзор онкоурологических материалов конгресса Американского общества клинической онкологии (ASCO) 2018 г.
Назранов3 1ФГБУ «Национальный медицинский исследовательский центр онкологии им.
В Чикаго (США) состоялся 54-й ежегодный конгресс Американского общества клинической онкологии (ASCO) с участием более 40 700 специалистов.
Summary
Обзор онкоурологических материалов конгресса Американского общества клинической онкологии (ASCO) 2018 г. Назранов3 1ФГБУ «Национальный медицинский исследовательский центр онкологии им. В Чикаго (США) состоялся 54-й ежегодный конгресс Американского общества клинической онкологии (ASCO) с участием более 40 700 специалистов. Для цитирования: Киричек А.А., Камолов Б.Ш., Матвеев В.Б., Назранов Б.М. Review of the oncological urology proceedings of the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting A.A. Kirichek, B.Sh. Kamolov, V.B. Matveev, B.M. Nazranov. A review of the most significant reports on cancer urology from the ASCO 2018 Annual Meeting is presented. For citation: Kirichek A.A., Kamolov B.Sh., Matveev V.B., Nazranov B.M. Review of the oncological urology proceedings of the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
